DALLAS, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to ...
New York, USA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix ...
Arog Pharmaceuticals, a late-stage biotech developing oral small molecule kinase inhibitors for cancer, filed on Friday with the SEC to raise up to $75 million in an initial public offering. The ...
Arog Pharmaceuticals presented new results from a Phase III trial at the American Society of Hematology (ASH) Annual Meeting 2025, held in Orlando, Florida and online from 6 to 9 December. The placebo ...
The US Food and Drug Administration@s (FDA) Office of Prescription Drug Promotion (OPDP) has issued an untitled letter@its third in 2018@to@Arog@Pharmaceuticals over promotional claims for its ...
DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to ...
Privately held Arog Pharmaceuticals Inc. won orphan drug status in Europe for crenolanib to treat acute myeloid leukemia (AML) and soft-tissue sarcoma. An orally available benzimidazole, crenolanib is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results